Award
National Cancer Institute 1R01CA299189-01A1
Gallium maltolate for the treatment of difficult-to-treat high-grade pediatric brain tumors
Recipient
Medical College of Wisconsin, Milwaukee, WI
Award Amount
$632,314.00
Ceiling
$632,314.00
Awarded
March 09, 2026
Identifier
1R01CA299189-01A1
This award funds research on gallium maltolate to treat aggressive pediatric brain tumors, aiming to improve survival and quality of life by targeting cancer iron metabolism and testing combination therapies.
Description
Research project focused on investigating gallium maltolate as a therapeutic agent for pediatric high-grade gliomas and atypical teratoid rhabdoid tumor (ATRT), aggressive pediatric brain tumors. The project aims to develop tissue sensitivity profiles and explore combination therapies with radiation.